Hemorrhoids Clinical Trial
Official title:
Randomized Double-blind Controlled Clinical Trial: the Use of Mesoglycan vs Placebo in the Acute Phase of Hemorrhoidal Disease
Hemorrhoidal disease (HD) is the most common proctological disease with a prevalence rate that can reach approximately 4.4% of the population, with a particular peak in individuals aged between 45 and 65 years. The most common presentation of HD is painless rectal bleeding occurring during or immediately after defecation. Pain is rare in case of uncomplicated HD and may be present in case of external hemorrhoidal thrombosis. The decision-making to treat Hemorrhoidal thrombosis usually depends on the timing of the onset of symptoms, with the surgical treatment favored if the onset of symptoms occurs within 72 hours. Mesoglycan, a natural preparation of glycosaminoglycans (GAGs), is a polysaccharide complex rich in sulfur radicals. It is composed of heparan sulphate (47.5%), dermatan sulphate (35.5%), chondroitin sulfate (8.5%) and slow heparin (8.5%). Mesoglycan exerts antithrombotic activity (activation of antithrombin III and heparin cofactor II) and profibrinolytic (stimulation of the activator tissue plasminogen) decreasing plasma concentrations of fibrinogen without affecting the prothrombin time, the time of partial thromboplastin or the remaining coagulation parameters. The rationale of this double-blind randomized controlled clinical trial is to confirm/evaluate the efficacy and safety of mesoglycan versus placebo in reducing the symptoms of hemorrhoidal disease and their impact on quality of life.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
| Withdrawn |
NCT02851940 -
Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids
|
N/A | |
| Recruiting |
NCT02301052 -
Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms
|
Phase 1/Phase 2 | |
| Completed |
NCT02216305 -
HAL-RAR Versus Hemorrhoidectomy in the Treatment of Grade III-IV Hemorrhoids. Prospective, Randomized Trial
|
N/A | |
| Completed |
NCT02358174 -
Hemorrhoids and Metalloproteinases, Observational Study
|
N/A | |
| Completed |
NCT01483833 -
Efficacy Study of Iferanserin to Treat Hemorrhoids
|
Phase 2 | |
| Completed |
NCT00397137 -
Stapled Anopexy Versus Closed Haemorrhoidectomy for Haemorrhoids
|
N/A | |
| Completed |
NCT00841620 -
Symptom Control 1-year After Circular Stapler Anopexy or Diathermy Excision for Prolapsed Haemorhoids
|
Phase 4 | |
| Completed |
NCT06459739 -
Effect of Sacral Erector Spinae Plane Block on Hemorrhoid and Pilonidal Sinus Surgery
|
N/A | |
| Completed |
NCT04276298 -
Topical Analgesia Post-Haemorrhoidectomy
|
Phase 2/Phase 3 | |
| Completed |
NCT04675177 -
Polidocanol Foam VS Artery Ligation in Hemorrhoidal Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05889962 -
Ultrasound-guided Pudendal Nerve Block for Pain After Hemorrhoidectomy
|
N/A | |
| Recruiting |
NCT01961739 -
Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT02061176 -
THD Versus Open Haemorrhoidectomy
|
N/A | |
| Withdrawn |
NCT00512044 -
Local Versus General Anaesthesia in Stapled Hemorrhoidectomy
|
Phase 4 | |
| Completed |
NCT04031131 -
The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids
|
Phase 2 | |
| Recruiting |
NCT04329364 -
RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty
|
Phase 2/Phase 3 | |
| Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
| Completed |
NCT04567485 -
Impact of Moderate to Severe Pain in the Post-intervention Monitoring Room After Hemorrhoidectomy on the Length of Stay in the Outpatient Surgery Unit
|
||
| Completed |
NCT03298997 -
Ligation and Hemorrhoidopexy Technique Versus Ligation of Hemorrhoidal Arteries Using Ultrasound for Hemorrhoids
|
N/A |